info@1med.ch

Italian CRO, LB Research, Joins the 1MED Group

1MED today announces that LB Research is now part of the 1MED Group. Established in 2007 and based in Como, Italy, LB Research is a full-service contract research organisation providing clinical trial management across all clinical product life cycle phases. LB Research operates with a highly skilled team of 24 professionals and maintains a diverse […]

TOP 5 most urgent tasks for MDR compliance before 2024

Following the success of the 1TALK event on November 30th, 1MED team is organizing in-depth webinars on the main regulatory and clinical issues necessary for the transition from MDD to MDR. The aim is to provide companies with clear information to create the necessary awareness to facilitate the adoption of MDR and offer information on […]

Discovery Pack – MDD to MDR

MDR Grace Period ends May 26th 2024. As this date approaches, manufacturers are requested to focus even more closely on how to plan transition for the legacy devices in their portfolio. For MDD to MDR transitions manufacturers are asking themselves: “Are we prepared for re-certification according to MDR?” “Do we have sufficient clinical data for […]

1MED’s New Partnership with Accenture!

We are thrilled to announce a game-changing collaboration between 1MED, a leading medical device CRO headquartered in Switzerland, and Accenture, a global leader in consulting and technology services. This partnership is set to revolutionize the landscape of the healthcare industry, empowering organizations to unlock new frontiers of innovation and accelerate the development of life-changing medical […]

1MED Unveils Ground-breaking Solutions to Navigate 2024 MDR

1MED a specialist Contract Research Organisation (“CRO”) providing clinical and regulatory support to medical devices companies, proudly announces its participation as a sponsor and exhibitor at the 12th Annual Outsourcing in Clinical Trials: Medical Devices Europe Conference in Munich. As the Medical Device Regulation (MDR) becomes fully applicable to all medical devices from 27 May […]

Evamed showcases comprehensive clinical support for medical device manufacturers at EUCROF24 

Evamed, a leading French clinical research company specialising in the evaluation and clinical investigation of medical devices – and part of the esteemed 1MED Group – is pleased to announce its participation at EUCROF24. At EUCROF 2024, Evamed will showcase its expertise in post-marketing support for medical device manufacturers, enhanced by the pre-marketing and clinical […]

Post-market surveillance for devices and IVDs: a focus on proactive data collection

The entry into force of the Regulation (EU) 2017/745 on devices  medical (Mdr) and the Regulation (EU) 2017/746 on devices ( medical diagnosticin vitro Ivdr) introduced a set of regulatory requirements on post-market surveillance (Pms), whose obligations all manufacturers of medical devices and in vitro diagnostic devices are required to follow, with the aim of […]

1MED INNOVATION DIGITAL FORUM

Il 3 Luglio si è tenuto il primo 1MED INNOVATION DIGITAL FORUM, un incontro virtuale che ha permesso di approfondire temi di attualità relativi alla prossima applicazione del Nuovo Regolamento sui Dispositivi Medici (UE) 2017/745 e del Nuovo Regolamento sulla Sperimentazione Clinica di medicinali per uso umano (UE) 536/2014. L’evento, dedicato principalmente alle aziende farmaceutiche […]